The removal of DNA interstrand cross-links (ICLs) has proven to be notoriously complicated due to the involvement of multiple pathways of DNA repair, which include the Fanconi anemia/BRCA pathway, homologous recombination and components of the nucleotide excision and mismatch repair pathways. Members of the SNM1 gene family have also been shown to have a role in mediating cellular resistance to ICLs, although their precise function has remained elusive. Here, we show that knockdown of Snm1B/Apollo in human cells results in hypersensitivity to mitomycin C (MMC), but not to IR. We also show that Snm1B-deficient cells exhibit a defective S phase checkpoint in response to MMC, but not to IR, and this finding may account for the specific sensitivity to the cross-linking drug. Interestingly, although previous studies have largely implicated ATR as the major kinase activated in response to ICLs, we show that it is activation of the ATMmediated checkpoint that is defective in Snm1B-deficient cells. The requirement for Snm1B in ATM checkpoint activation specifically after ICL damage is correlated with its role in promoting double-strand break formation, and thus replication fork collapse. Consistent with this result Snm1B was found to interact directly with Mus81-Eme1, an endonuclease previously implicated in fork collapse. In addition, we also show that Snm1B interacts with the Mre11-Rad50-Nbs1 (MRN) complex and with FancD2 further substantiating its role as a checkpoint/DNA repair protein.
Introduction
The budding yeast snm1/pso2 mutant was first isolated over 25 years ago and exhibits a singular sensitivity to DNA interstrand cross-linking agents, but not to other forms of DNA damage such as ionizing radiation ultraviolet (IR and UV) or monofunctional alkylating agents (Henriques and Moustacchi, 1980; Ruhland et al., 1981; Haase et al., 1989) . The molecular function of yeast Snm1 remains poorly defined. Mutants of snm1/ pso2 appear normal in the initial processing steps of interstrand cross-link (ICL) repair, but are defective in the resolution of double-strand breaks (DSBs) that occur presumably as a consequence of replication fork collapse in response to ICLs (Magana-Schwencke et al., 1982; Wilborn and Brendel, 1989; Li and Moses, 2003; Barber et al., 2005) . Interestingly, Snm1 has been shown to have an overlapping role with the 5 0 -3 0 mismatch repair exonuclease Exo1 during processing of collapsed replication forks via homologous recombination (Barber et al., 2005) . It was also shown in this same report that Snm1 has a separate role in G1 phase repair of ICLs that requires the nucleotide excision repair pathway, but not homologous recombination. Thus, Snm1 plays a role in both homology-dependent and homology-independent pathways of ICL repair in Saccharomyces cerevisiae (Grossmann et al., 2001) .
In chicken and mammalian cells three orthologues of SNM1 have been identified that are involved in the cellular response to genotoxic agents (Dronkert et al., 2000; Ishiai et al., 2004) . These genes include SNM1A, SNM1B/Apollo and Artemis. All of the SNM1 orthologues have in common a metallo-b-lactamase fold and an appended b-CASP (CPSF-Artemis-Snm1-Pso2) domain (Callebaut et al., 2002) , which together are sometimes referred to as the SNM1 domain. The b-CASP domain is predicted to be a nucleic acid binding domain, and together with the metallo-b-lactamase fold has been shown to constitute a nuclease function in the Snm1 proteins (Chan et al., 2002; Pannicke et al., 2004; Li et al., 2005; Lenain et al., 2006) . Outside of the SNM1 domain the sequence of each of the proteins is distinct. Artemis, which is the most intensively studied member of the SNM1 gene family, is known to be required in partnership with DNA-PKcs for the cleavage of hairpins that occur at coding joints during V(D)J recombination (Ma et al., 2002) . The inability to complete V(D)J recombination in Artemis-deficient cells has been shown to lead to a SCID (severe combined immunodeficiency) syndrome (Moshous et al., 2000 (Moshous et al., , 2001 . In addition, Artemis-deficient cells are radiosensitive, and this phenotype has been ascribed to both a deficiency in nonhomologous end-joining and cell cycle checkpoint responses (Ma et al., 2002; Riballo et al., 2004; Zhang et al., 2004; Wang et al., 2005; Geng et al., 2007) . A knockout of Artemis in the mouse has recapitulated the SCID syndrome and has also shown that it is a tumor suppressor, but only when combined with p53 deficiency (Rooney et al., 2002 (Rooney et al., , 2004 . Studies of SNM1A have been to an extent less revealing. Snm1A has been shown to colocalize with Mre11 foci after exposure of cells to IR or ICL-inducing agents, and to interact with the checkpoint protein 53BP1 (Richie et al., 2002) . However, mammalian SNM1A-deficient cells exhibit no hypersensitivity to IR and only a modest hypersensitivity to interstrand cross-linking agents (Dronkert et al., 2000; Ahkter et al., 2005) , although sensitivity to cisplatin has been observed in chicken DT40 cells (Ishiai et al., 2004; Nojima et al., 2005) . Intriguingly, Snm1A-deficient mouse embryonic fibroblasts are highly sensitive to spindle poisons such as nocodazole and taxol, and Snm1A has been shown to be involved in an early mitotic checkpoint pathway in response to these drugs (Akhter et al., 2004) . This mitotic checkpoint pathway appears to be congruent with that involving the Chfr tumor suppressor gene (Scolnick and Halazonetis, 2000; Chaturvedi et al., 2002; Matsusaka and Pines, 2004; Summers et al., 2005; Yu et al., 2005) . A knockout of Snm1A in the mouse has shown that it too is a tumor suppressor gene (Ahkter et al., 2005) .
Only a few studies have been conducted on the DNA repair function of SNM1B in vertebrate cells. In chicken DT40 cells lack of SNM1B results in a slight to moderate increased sensitivity to cisplatin and mitomycin C (MMC), but not to IR (Ishiai et al., 2004; Nojima et al., 2005) . In human cells siRNA-mediated knockdown of SNM1B has been shown to result in moderate hypersensitivity to cisplatin, MMC and IR (Demuth et al., 2004) . Also, several recent papers have demonstrated a novel function for Snm1B/Apollo namely that it interacts with the telomere protein TRF2 and protects telomeres from the DNA repair machinery during S phase (Freibaum and Counter, 2006; Lenain et al., 2006; van Overbeek and de Lange, 2006) .
The mechanisms of ICL repair are still poorly understood in mammalian cells. This situation is particularly true for the early stages of repair involving replication fork collapse and uncoupling of the ICL. Here, we found, consistent with a previous report (Demuth et al., 2004) , that SNM1B-deficient cells are hypersensitive to interstrand cross-linking agents, however, we did not observe an increased sensitivity to IR. Significantly, we find that SNM1B is required for the induction of an S phase checkpoint after exposure of cells to MMC, but not to IR. The loss of the S phase checkpoint in SNM1B-deficient cells is due to an inability to activate ATM, Chk2 and Nbs1. This failure to activate ATM and downstream targets is due to the absence of replication fork collapse and the production of DSBs. We also show that Snm1B physically associates with Mre11, FancD2 and Mus81, suggesting that it may be involved in recruiting or maintaining these ICL response proteins at the site of the lesion and/ or stalled replication fork.
Results
The role of SNM1B in DNA repair processing of ICLs To initiate our studies of SNM1B, we isolated stable clones of HEK293T cells expressing a small hairpin RNA (shRNA) targeted to this gene. Two clones, designated no. 5 and no. 7, were identified with significant knockdown of Snm1B as indicated by immunoblotting with clone 5 exhibiting the greater depletion of the protein (Figure 1a) . A clone expressing a nonspecific shRNA was also derived as a control. These clones were analysed for sensitivity to agents that introduce DNA ICLs or to IR. Consistent with a previous report (Demuth et al., 2004) , the SNM1B-deficient cells exhibited hypersensitivity to three crosslinking drugs tested, although a significantly higher degree of cell killing was observed with MMC as opposed to cisplatin or psoralen plus UVA (Figure 1b and results not shown). However, no increased sensitivity was observed upon exposure to IR (Figure 1c ) or UV ( Figure 1d ). Consistently, clone 5 showed the greatest hypersensitivity in agreement with the lower level of Snm1B in this clone.
To directly assess the role of putative DNA repair genes in ICL repair, we have developed a number of plasmid-based in vivo assays that measure the involvement of various DNA repair pathways including nucleotide excision repair, homology dependent recombination (HDR), and single-strand annealing (SSA). These assays utilize plasmids that contain site-specific psoralen ICLs, and have been designed to interrogate a particular DNA repair pathway (Wang et al., 2001; Zheng et al., 2003 Zheng et al., , 2006 Shen et al., 2006; Zhang et al., 2007) . In the recombination-indepenent repair assay, which measures repair of ICLs mediated by nucleotide excision repair and translesion bypass synthesis, the no. 5 clone showed an approximate twofold reduction in the reactivation of cross-linked plasmids compared to control cells ( Figure 1e ). As noted above, the yeast snm1 mutant also exhibits a defect in G1 phase repair of ICLs (Barber et al., 2005) . This result is to be compared to XPA-deficient cells that showed an approximate 10-fold reduction in reactivation. As a control for the specificity of this effect, a construct expressing a SNM1B allele resistant to the shRNA-mediated knockdown was able to fully rescue the reactivation assay. Surprisingly, a point mutant (D14N) of SNM1B was also able to fully rescue the reactivation assay. In Artemis, mutation of this residue, located in the metallob-lactamase domain and conserved in all SNM1 family C-XPA indicates a clone with stable correction of the XPA cell line. SNM1B R indicates an allele refractory to the SNM1B shRNA. D14N indicates a point mutation of SNM1B in the metallo-b-lactamase domain. All assays were carried out in triplicate and s.d. are indicated. (f) SNM1B-deficient cells show no defect in homology dependent recombination (HDR) of a linearized cross-linked substrate. pECFPHR contains a donor ECFP gene without a start codon and an interrupted ECFP gene due to the insertion of an oligonucleotide, with or without a psoralen cross-link, within the coding region . The ratio of homologous recombination in cross-linked plasmids to homologous recombination in non-cross-linked plasmids is presented as ICL stimulation of HDR. (g) SNM1B-deficient cells exhibit increased levels of repair by SSA. Psoralen-crosslinked (left panel) or non-crosslinked, linearized (right panel) pSupN plasmids were transfected into the indicated cell lines. For the rescue experiment the control (GFP) and SNM1B DNAs were co-transfected with the pSupN plasmid. Recombination frequency refers to percentage of blue colonies derived from more than 10 000 total colonies. ICL, interstrand cross-links; shRNA, small hairpin RNA; SSA, single-strand annealing.
Snm1B/Apollo mediates replication fork collapse J-B Bae et al members, has been shown to inactivate the nuclease activity of the protein (Pannicke et al., 2004) . In contrast to the results with the recombination-indepenent repair assay, the no. 5 clone showed no defect in the HDR assay ( Figure 1f ). This assay is performed with a linearized plasmid DNA that contains an ICL near the broken end, thus, mimicking a collapsed replication fork . FANCD2-deficient cells, which are defective in HDR of ICLs (Nakanishi et al., 2005; Thompson et al., 2005) , are also highly defective in this assay . Thus, these results suggest that Snm1B is not directly involved in the recombination steps of fork restoration during ICL repair. We also examined the no. 5 clone in an assay that measures the single-strand annealing (SSA) pathway during repair of ICLs (Zheng et al., 2006) . Interestingly, the no. 5 clone showed an approximate threefold increase in ICL repair by SSA, suggesting that the lack of Snm1B results in a funneling of these lesions into the SSA pathway ( Figure 1g ). Expression of the shRNA refractory construct reverted the SSA response to normal levels.
To further define the phenotype of cells deficient in Snm1B, we conducted a number of assays to assess its role in maintenance of genomic stability. Mutants defective in ICL repair typically exhibit chromosomal aberrations upon exposure to cross-linking drugs. Treatment of clone 5 with either MMC or cisplatin caused an approximate 2-3 fold increase in the total number of chromosomal aberrations (Figures 2a and b) , which is similar to the levels observed in the highly MMC-sensitive Mus81 nullizygous mouse cells (McPherson et al., 2004) . Abnormal chromosome structures can result in an aberrant mitosis leading to mitotic catastrophe and the formation of micronuclei. Exposure of the no. 5 clone to MMC showed that approximately a quarter of the cells exhibited micronuclei, whereas no such aberrant nuclei were observed in the control cell line (Figures 2c and d) . Taken together, our findings suggest that Snm1B is involved in repair processing of ICLs as lowered levels of the protein result in increased chromosomal aberrations in response to ICL-inducing drugs. However, the DNA repair assays suggest that Snm1B likely acts upstream of the recombinational processing steps of ICL repair.
SNM1B is required for the S phase cell cycle checkpoint in response to ICL damage Next, we examined the cell cycle response after exposure of Snm1-deficient cells to ICLs. FACS (fluorescenceactivated cell sorting) analysis after treatment with MMC resulted in a strong G2/M accumulation in clone no. 5 cells compared to the control cells (Figures 3a and  b) . To verify the generality of this effect, we transiently knocked down SNM1B in HeLa cells using an siRNA that targets a different region of SNM1B than the shRNA used to develop the stable knockdown clones in HEK293T cells. Treatment of these cells with MMC again resulted in an increased G2/M accumulation compared to control cells (Supplementary Figure S1 ). G2/M or late S phase accumulation after DNA damage is also observed in FA cells (Seyschab et al., 1995; Akkari et al., 2001) , and may be due to a failure to repair, and/or to a defect in the S phase checkpoint. Such a phenotype has been observed in ATM-and BRCA1-deficient cells after IR-induced DNA damage and has been attributed to a S phase checkpoint defect . To determine if SNM1B-deficient cells are defective in an S phase checkpoint, we examined the effect on DNA synthesis of exposure of cells to MMC. As shown (Figure 3c ), treatment of either clone 5 or 7 with MMC did not result in decreased DNA synthesis as observed in the control cells indicating a failure to arrest cells in S phase, and thus a defective checkpoint. A similar defect in the intra-S phase checkpoint has been DNA synthesis was evaluated (as described in Experimental Procedures) with the indicated clones after treatment with MMC (10 mg/ml for 1 h), or as a function of IR dose. (e) The hydrolase activity of Snm1B is not required for rescue of the G2/M accumulation phenotype. The indicated clones were either treated with MMC (50 ng/ml) for 24 h or not treated, and then analysed by FACS. For the rescue experiments (lower panels), the indicated SNM1B constructs were transfected into no. 5 cells, and 24 h later MMC was added for an additional 24 h. The Snm1B proteins were tagged with EGFP and only the GPF-positive cell populations as determined by FACS analysis are shown. The SNM1B alleles are as described in Figure 3a , except for SNM1DCD, which lacks the entire conserved domain (metallo-b-lactamase plus b-CASP).
Snm1B/Apollo mediates replication fork collapse J-B Bae et al although this has been observed in FA cells Ho et al., 2006) . These latter experiments were conducted as a function of IR dose to examine the S phase checkpoint over a wide degree of DNA damage. These findings indicate that SNM1B is required for the enforcement of an S phase checkpoint specifically in response to ICLs, but not to DSBs introduced by IR. To demonstrate that these observed cell cycle effects are specific to SNM1B knockdown, we attempted a rescue with shRNA-refractory constructs. As shown (Figure 3e ), both wild-type SNM1B and the D14N mutant were able to rescue the G2/M accumulation phenotype, whereas, a mutant (DCD) with the entire SNM1 conserved domain deleted was unable to achieve a rescue.
Snm1B is required for checkpoint signaling in response to ICL damage As SNM1B is required for the S phase checkpoint in response to ICL damage, we next examined whether known markers of checkpoint activation were affected by its knockdown. Phosphorylation of the Nbs1 serine 343 residue (S343) is known to occur in response to both IR and ICL damage. Examination of clone 5 showed that in response to MMC, but not to IR, there was defective phosphorylation of this residue (Figure 4a ). This result is consistent with the findings shown above (Figure 3) indicating that SNM1B-deficient cells are defective in an S phase checkpoint in response to ICL damage, but not IR-induced DSBs. Chk1 is also known to be phosphorylated by ATR after ICL damage (Pichierri and Rosselli, 2004b) . We, therefore, examined the phosphorylation of Chk1 and as a control Chk2 after MMC treatment. Interestingly, the phosphorylation of Chk1 was unaffected in the clone 5 cells, whereas, the phosphorylation of Chk2 was strongly reduced (Figure 4b, upper panel) . However, Chk2 phosphorylation was not affected after exposure of cells to IR (Figure 4b, lower panel) . Chk2 is typically a substrate of ATM as opposed to ATR, we, therefore, examined the activation of ATM as indicated by phosphorylation at the S1981 residue, which is a marker for activation of this kinase (Bakkenist and Kastan, 2003) . As shown (Figure 4c) , activation of ATM after MMC treatment is reduced in clone 5 compared to control cells. Finally, monoubiquitination of FancD2 by the FA core complex is a hallmark of fork stalling in response to ICLs. We, however, found no defect in this modification in Snm1B-depleted cells after treatment with MMC indicating that this branch of the signaling pathways is intact (results not shown), consistent with the finding reported by (Demuth et al., 2004) .
Snm1B interacts with MRN and FancD2
Mre11, Rad50 and Nbs1 form a complex, referred to as MRN, that has been implicated in both DNA repair processing and cell cycle checkpoint signaling in response to ICLs (Nakanishi et al., 2002; Pichierri et al., 2002; Pichierri and Rosselli, 2004b) . In addition, FancD2 and Nbs1 have been shown to colocalize in MMC-induced nuclear foci, and to co-IP together (Nakanishi et al., 2002) . We performed co-IP experiments to determine whether Snm1B interacts with proteins known to be involved in the cellular ICL response. A positive interaction was found for FancD2 (Figures 5a and b) , and Mre11 and Rad50 (Figures 5c-e . The NS and no. 5 clones were treated with MMC (50 ng/ml) continuously or to IR (2 Gy), and harvested at the indicated time points for immunoblotting. (b) Phosphorylation of Chk2, but not Chk1, is defective in SNM1B knockdown cells upon exposure to MMC. The NS and no. 5 clones were continuously exposed to MMC (300 ng/ml) or to IR (2 Gy) for the indicated times. (c) Activation of ATM is defective in SNM1B knockdown cells. The NS and no. 5 clones were continuously exposed to MMC (300 ng/ml) for the indicated times.
Snm1B/Apollo mediates replication fork collapse J-B Bae et al mediated these interactions, several deletion constructs of Snm1B were prepared and examined in the co-IP assay. Interestingly, both the Mre11 and FancD2 interaction domains mapped to the same region of Snm1B located near the C-terminal end of the b-CASP domain (Figures 5f-h ), although it should be noted that Snm1B/Apollo mediates replication fork collapse J-B Bae et al while this region is necessary, it may not be sufficient for these interactions. Co-IP assays performed with purified recombinant proteins showed that Snm1B does not directly interact with FancD2 (results not shown), but does appear to directly interact with the MRN complex (Figure 5i ).
Snm1B is required for replication fork collapse at ICLs
Our findings thus far indicate that Snm1B is required for the activation of ATM and Chk2 upon treatment with MMC, but not after exposure to IR. ATM is principally activated after induction of DSBs, thus, one possible explanation for our results is that Snm1B is required for the introduction of DSBs that occur during replication fork collapse in response to ICLs. To test this hypothesis, we used pulsed-field gel electrophoresis to separate intact chromosomes from broken DNA after exposure of cells to MMC (Hanada et al., 2006; Mladenov et al., 2007) . As shown, clone 5 cells showed both a delay and an overall reduction in the amount of broken DNA compared to control cells indicating that Snm1B is required for replication fork collapse (Figure 6a and b) , thus validating our hypothesis.
Recently, it has been shown that the structure-specific endonuclease Mus81-Eme1 is required for replication fork collapse after treatment with MMC (Hanada et al., 2006) . We, therefore, tested whether Snm1B and Mus81-Eme1 interact with each other. Antibodies to Snm1B were found to robustly co-IP Mus81, and this interaction was confirmed by a reciprocal co-IP with Mus81 antibodies (Figure 6c ). To further define this interaction, we mapped the Mus81-Eme1 interaction site on Snm1B, and were able to limit it to within the metallo-blactamase domain (Figures 6d and e) , although it is possible that other regions of Snm1B are involved in mediating this interaction. Nevertheless, the interaction between Mus81-Eme1 and Snm1B is distinct from the interaction described above for Snm1B with FancD2 and the MRN complex. Finally, we used affinitypurified recombinant preparations of glutathione S-transferase (GST)-Snm1B and HA-Mus81-Eme1 to demonstrate that the interaction between these proteins is direct (Figure 6f ). Taken together, these findings suggest that Snm1B and Mus81-Eme1 cooperate together in mediating replication fork collapse in response to ICLs.
Discussion
In this study, we have shown that Snm1B is uniquely involved in the cellular response to ICLs in DNA, but is not involved in the response to frank DSBs created by IR. This unique role is explained by our finding that Snm1B is required for induction of DSBs that occur at replication forks as they encounter an ICL. Until recently it was not clear whether replication fork collapse was a regulated biochemical process or an unintended consequence of long-term fork stalling mediated by mechanical processes. The discovery that the structure specific endonuclease Mus81-Eme1 is specifically required for DSB formation suggested that the former view is likely correct (Hanada et al., 2006) . Moreover, it seems highly probable that fork collapse is a necessary, if drastic, step for the eventual removal of the ICL. The finding that Mus81-Eme1 and Snm1B directly interact with each other strengthens the conclusion that both of these proteins participate in actively promoting DSBs in response to ICLs. Interestingly, although the SNM1 gene family has been shown to possess nucleic acid processing activity mediated through its conserved metallo-b-lactamase and b-CASP domains (Ma et al., 2002; Pannicke et al., 2004; Li et al., 2005; Lenain et al., 2006; Dominski, 2007) , inactivation of the hydrolase domain of Snm1B by a point mutation did not affect the normal cell cycle response to fork collapse. This result suggests that Mus81-Eme1 is likely the actual endonuclease forming the DSB, whereas Snm1B may be required to either recruit or maintain Mus81-Eme1 at the site of the stalled replication fork. Interestingly, the metallo-b-lactamase domain of Snm1B is required for the interaction with Mus81-Eme1 indicating that in addition to its hydrolase function this domain also mediates protein-protein interactions. Our results also suggest that Snm1B may not be involved in the subsequent recombinational steps of ICL repair as it was not required in the HDR assay , which measures ICL-stimulated gene conversion in conjunction with a DSB. Furthermore, Snm1B did not interact with Rad51. These results are in contrast to Mus81, which interacts directly with the recombination protein Rad54, and appears to act in the same pathway of ICL repair (Interthal and Heyer, 2000; Hanada et al., 2006) . Nevertheless, as fork collapse is likely required for the ultimate excision and uncoupling of the ICL, Snm1B would be a necessary element for the repair of these lesions via an S phase repair pathway.
Previous studies have shown that the ATR-mediated checkpoint signaling pathway is activated in response to ICLs detected in the S phase of the cell cycle. As shown (Figure 7) , ATR signaling is composed of two branches represented by the ATR-Chk1 subpathway and a second branch involving ATR-Nbs1-FancD2 Pichierri and Rosselli, 2004b; Nakanishi et al., 2005) . The former pathway, whose target is Cdc25A, is well understood, whereas less is known about the second branch, which involves ATR-mediated Nbs1-dependent phosphorylation of FancD2 and subsequent ubiquitylation by the FA core complex (Andreassen et al., 2004; Stiff et al., 2005) . How this latter pathway interacts with the cell cycle machinery is not clear at present. Our findings indicate that, in addition to the ATR-mediated pathways, subsequent to DSB induction and fork collapse, ATM-mediated checkpoint pathways are also activated. Similar to the ATR pathways, ATM signaling is also mediated by two parallel pathways involving ATM-Chk2 and ATM-Nbs1-Smc1 Lambert and Carr, 2005) . The involvement of ATM in checkpoint signaling in response to ICLs has not been previously described, and in fact experiments to detect such an involvement have largely proven negative (Pichierri and Rosselli, 2004b; Mladenov et al., 2007) . This situation is likely due to the fact that activation of ATM only occurs after fork collapse, which usually takes place many hours after introduction of the ICLinducing drug, whereas most checkpoint assays are performed within a few hours of drug treatment. High drug concentrations can likely accelerate this process, which is presumably why we were able to detect a Snm1B/Apollo mediates replication fork collapse J-B Bae et al defective checkpoint response at early times in the absence of Snm1B. Thus, in response to ICLs there appears to be an early and possibly transient checkpoint activation mediated by ATR in response to fork stalling (Pichierri and Rosselli, 2004a, b) , and a later checkpoint activation mediated by ATM in response to formation of DSBs at stalled forks ( Figure 7 ). Snm1B is involved in this later checkpoint activation through its role in mediating fork collapse in collaboration with Mus81-Eme1. We also did not observe an effect on the monoubiquitylation of FancD2 in the SNM1B knockdown cells which is consistent with this modification being ATR-but not ATM-dependent in response to ICL damage .We cannot rule out that Snm1B might have additional direct role(s) in checkpoint signaling such as the activation of Nbs1 by either ATM or ATR, as Nbs1 phosphorylation appears to be highly compromised after ICL damage in the SNM1B knockdown cells. This contention is supported by our finding that Snm1B directly interacts with the MRN complex. The functional significance of this interaction requires further investigation, however, there are at least two possibilities. One is that the MRN complex is involved in recruiting Snm1B specifically to stalled replication forks at ICLs to promote fork collapse, and a second is that Snm1B arrives early at the stalled fork and subsequently is involved in recruiting MRN, FancD2 and Mus81-Eme1. Together our findings demonstrate that Snm1B is specifically involved in mediating resistance to ICLinducing compounds by its role in promoting replication fork collapse, which leads to activation of ATMmediated cell cycle arrest and likely initiation of removal of the lesion. As Snm1B/Apollo has also been implicated in telomere protection during S phase (Freibaum and Counter, 2006; Lenain et al., 2006; van Overbeek and de Lange, 2006) , it is clear that it has a multifunctional role in maintenance of genomic stability, and experiments designed to assess its role as a tumor suppressor merit further investigation.
Materials and methods
shRNA-mediated stable knockdown of Snm1B expression HEK293T cells were transfected with an shRNA vector (Open Biosystems, Huntsville, AL, USA) targeted for SNM1B (target sequence: 5 0 gaaacagatccatacttta) and a nonspecific shRNA control vector. Positive clones were selected in Puromycin (2.5 mg/ml), and knockdown of Snm1B was confirmed by immunoblotting. For immunoblotting rabbit polyclonal antibodies against Snm1B were generated using a polypeptide encompassing the region (residues 304-532) of the protein not conserved in other family members.
Clonogenic cell survival assay Cells were plated to achieve a final colony density of approximately 100-300 colonies per 10 cm dish. One day after plating irradiation was performed or drugs were added, and the medium was left unchanged until colonies appeared. Cells were fixed and stained with 10% crystal violet in 100% ethanol.
Chromosome analysis
Chromosome analyses were performed as described previously (Multani et al., 2000) . At least 35 metaphases were analysed from each sample for chromosome aberrations.
In vivo plasmid-based DNA repair assays Preparation of cross-linked plasmids, and assays for recombination-independent repair (Wang et al., 2001; Zheng et al., 2003) , SSA (Zheng et al., 2006) and homology-dependent repair were carried out as described.
Site directed mutagenesis
The QuikChange Site Directed Mutagenesis Kit (Invitrogen, Carlsbad, CA, USA) was used to prepare mutated SNM1B constructs. Primers used for the shRNA resistant clone (SNM1B) were: 5 0 gggaagcaaatccacaccttatacc and 5 0 ggtataaggt gaggatttgcttccc. Primers used for the D14N point mutation were: 5 0 gcccatcgcagtgaacttctggagcc and 5 0 ggctccagaagttcactg cgatgggc.
Co-immunoprecipitation and pull-down assays Cells were grown in 60 mm plates, washed with cold PBS twice, and lysed by adding 500 ml of EBC buffer (50 mM Tris-HCl (pH 8.0), 120 mM NaCl, 0.5% NP-40, 1 mM phenylmethylsulfonyl fluoride) on ice for 20 min. In some cases, cells were transfected with a construct (pDEST27-SNM1B) expressing a GST-Snm1B fusion protein and incubated for 2 days prior to extract preparation. Lysate preparation and co-IP assays were performed as described previously .
Pull-down assays with purified recombinant proteins were conducted essentially as described previously . GST-Snm1B and HA-Mus81-Eme1 were expressed in Escherichia coli and Sf9 insect cells, respectively. Both proteins were purified by affinity chromatography.
Evaluation of DNA synthesis
To analyse inhibition of DNA synthesis by MMC and IR (Painter and Young, 1980) , cells were prelabeled with 14 C-thymidine (50 nCi/ml) for 1 day. Cells were treated either with MMC (10 mg/ml) for 1 h or different doses of IR, and H-thymidine (10 mCi/ml) for 15 min before harvesting. Cells were fixed with 70% methanol and radioactivity was measured by scintillography. The degree of DNA synthesis was derived from the resulting ratios of 3 H to 14 C counts per minute and expressed as a percentage of untreated cells.
Detection of DSBs by pulsed-field gel electorphoresis Subconfluent cell cultures were treated with 1 mg/ml of MMC for different times. Cells were harvested after trypsinization, and agarose plugs containing 10 6 cells were prepared and DNAs separated by pulse-field gel electrophoresis as described previously (Hanada et al., 2006; Mladenov et al., 2007) .
